BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22614965)

  • 1. The role of adjuvant chemotherapy in early-stage and locally advanced non-small cell lung cancer.
    Shapiro M
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS42-5. PubMed ID: 22614965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting response to chemotherapy with early-stage lung cancer.
    Rosell R; Taron M; Massuti B; Mederos N; Magri I; Santarpia M; Sanchez JM
    Cancer J; 2011; 17(1):49-56. PubMed ID: 21263267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coming of age of molecular tumor profiling.
    Antonoff MB; D'Cunha J
    Semin Thorac Cardiovasc Surg; 2011; 23(1):8-9. PubMed ID: 21807290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
    Socinski MA
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):27-33. PubMed ID: 10566608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
    Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M
    N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
    Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of targeted agents in adjuvant therapy for non-small cell lung cancer.
    Kelly K
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5027s-5029s. PubMed ID: 16000608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
    Tiseo M; Franciosi V; Grossi F; Ardizzoni A
    Eur J Cancer; 2006 Jan; 42(1):8-16. PubMed ID: 16293409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in non-small cell lung cancer.
    Le Chevalier T
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):62-5. PubMed ID: 9728587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
    Belani CP
    Clin Lung Cancer; 2003 Jul; 5(1):11-2. PubMed ID: 14596696
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-operative adjuvant chemotherapy for non-small-cell lung cancer].
    Nakagawa K; Yasumitu T
    Nihon Rinsho; 2002 May; 60 Suppl 5():442-5. PubMed ID: 12101710
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adjuvant chemotherapy in non-small cell lung cancer].
    Taillade L; Soria JC; André F; Grunenwald D; Dunant A; Pignon JP; Le Chevalier T
    Bull Cancer; 2004 Jan; 91(1):63-7. PubMed ID: 14975806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.